183 related articles for article (PubMed ID: 29290998)
1. Detection of somatic variants and
Sung JS; Chong HY; Kwon NJ; Kim HM; Lee JW; Kim B; Lee SB; Park CW; Choi JY; Chang WJ; Choi YJ; Lee SY; Kang EJ; Park KH; Kim YH
Oncotarget; 2017 Dec; 8(63):106901-106912. PubMed ID: 29290998
[TBL] [Abstract][Full Text] [Related]
2. Multiplex picoliter-droplet digital PCR for quantitative assessment of EGFR mutations in circulating cell-free DNA derived from advanced non-small cell lung cancer patients.
Yu Q; Huang F; Zhang M; Ji H; Wu S; Zhao Y; Zhang C; Wu J; Wang B; Pan B; Zhang X; Guo W
Mol Med Rep; 2017 Aug; 16(2):1157-1166. PubMed ID: 29067441
[TBL] [Abstract][Full Text] [Related]
3. Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer.
Sacher AG; Paweletz C; Dahlberg SE; Alden RS; O'Connell A; Feeney N; Mach SL; Jänne PA; Oxnard GR
JAMA Oncol; 2016 Aug; 2(8):1014-22. PubMed ID: 27055085
[TBL] [Abstract][Full Text] [Related]
4. Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR.
Watanabe M; Kawaguchi T; Isa S; Ando M; Tamiya A; Kubo A; Saka H; Takeo S; Adachi H; Tagawa T; Kakegawa S; Yamashita M; Kataoka K; Ichinose Y; Takeuchi Y; Sakamoto K; Matsumura A; Koh Y
Clin Cancer Res; 2015 Aug; 21(15):3552-60. PubMed ID: 25882755
[TBL] [Abstract][Full Text] [Related]
5. Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value.
Alegre E; Fusco JP; Restituto P; Salas-Benito D; Rodríguez-Ruiz ME; Andueza MP; Pajares MJ; Patiño-García A; Pio R; Lozano MD; Gúrpide A; Lopez-Picazo JM; Gil-Bazo I; Perez-Gracia JL; Gonzalez A
Tumour Biol; 2016 Oct; 37(10):13687-13694. PubMed ID: 27473086
[TBL] [Abstract][Full Text] [Related]
6. Detection of somatic mutations in cell-free DNA in plasma and correlation with overall survival in patients with solid tumors.
Mehrotra M; Singh RR; Loghavi S; Duose DY; Barkoh BA; Behrens C; Patel KP; Routbort MJ; Kopetz S; Broaddus RR; Medeiros LJ; Wistuba II; Luthra R
Oncotarget; 2018 Feb; 9(12):10259-10271. PubMed ID: 29535804
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02).
Lee JY; Qing X; Xiumin W; Yali B; Chi S; Bak SH; Lee HY; Sun JM; Lee SH; Ahn JS; Cho EK; Kim DW; Kim HR; Min YJ; Jung SH; Park K; Mao M; Ahn MJ
Oncotarget; 2016 Feb; 7(6):6984-93. PubMed ID: 26755650
[TBL] [Abstract][Full Text] [Related]
8. Total DNA input is a crucial determinant of the sensitivity of plasma cell-free DNA EGFR mutation detection using droplet digital PCR.
Zhang Y; Xu Y; Zhong W; Zhao J; Chen M; Zhang L; Li L; Wang M
Oncotarget; 2017 Jan; 8(4):5861-5873. PubMed ID: 28052016
[TBL] [Abstract][Full Text] [Related]
9. Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial.
Karachaliou N; Mayo-de las Casas C; Queralt C; de Aguirre I; Melloni B; Cardenal F; Garcia-Gomez R; Massuti B; Sánchez JM; Porta R; Ponce-Aix S; Moran T; Carcereny E; Felip E; Bover I; Insa A; Reguart N; Isla D; Vergnenegre A; de Marinis F; Gervais R; Corre R; Paz-Ares L; Morales-Espinosa D; Viteri S; Drozdowskyj A; Jordana-Ariza N; Ramirez-Serrano JL; Molina-Vila MA; Rosell R;
JAMA Oncol; 2015 May; 1(2):149-57. PubMed ID: 26181014
[TBL] [Abstract][Full Text] [Related]
10. Detection of Plasma EGFR Mutations in NSCLC Patients with a Validated ddPCR Lung cfDNA Assay.
Guo QM; Wang L; Yu WJ; Qiao LH; Zhao MN; Hu XM; Sun YM; Ni S; Xu YH; Lou JT
J Cancer; 2019; 10(18):4341-4349. PubMed ID: 31413754
[No Abstract] [Full Text] [Related]
11. Estimation of cell-free circulating EGFR mutation concentration predicts outcomes in NSCLC patients treated with EGFR-TKIs.
Zhu YJ; Zhang HB; Liu YH; Zhang FL; Zhu YZ; Li Y; Bai JP; Liu LR; Qu YC; Qu X; Chen X; Li Y; Zheng GJ
Oncotarget; 2017 Feb; 8(8):13195-13205. PubMed ID: 28061461
[TBL] [Abstract][Full Text] [Related]
12. Association of mutant EGFR L858R and exon 19 concentration in circulating cell-free DNA using droplet digital PCR with response to EGFR-TKIs in NSCLC.
Zhu YJ; Zhang HB; Liu YH; Zhu YZ; Chen J; Li Y; Bai JP; Liu LR; Qu YC; Qu X; Chen X; Zheng GJ
Oncol Lett; 2017 Aug; 14(2):2573-2579. PubMed ID: 28789464
[TBL] [Abstract][Full Text] [Related]
13. Development, validation, and comparison of gene analysis methods for detecting
Hanibuchi M; Kanoh A; Kuramoto T; Saito T; Tobiume M; Saijo A; Kozai H; Kondo M; Morizumi S; Yoneda H; Kagawa K; Ogino H; Sato S; Kawano H; Otsuka K; Toyoda Y; Nokihara H; Goto H; Nishioka Y
Oncotarget; 2019 Jun; 10(38):3654-3666. PubMed ID: 31217900
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients.
Xiong L; Cui S; Ding J; Sun Y; Zhang L; Zhao Y; Gu A; Chu T; Wang H; Zhong H; Ye X; Gu Y; Zhang X; Hu M; Jiang L
Oncotarget; 2017 Sep; 8(38):63846-63856. PubMed ID: 28969034
[TBL] [Abstract][Full Text] [Related]
15. Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system.
Suzawa K; Yamamoto H; Ohashi K; Hashida S; Tomida S; Kubo T; Maki Y; Soh J; Tsukuda K; Kiura K; Miyoshi S; Toyooka S
Oncol Rep; 2017 May; 37(5):3100-3106. PubMed ID: 28405680
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of pre-analytical conditions and comparison of the performance of several digital PCR assays for the detection of major
Garcia J; Dusserre E; Cheynet V; Bringuier PP; Brengle-Pesce K; Wozny AS; Rodriguez-Lafrasse C; Freyer G; Brevet M; Payen L; Couraud S
Oncotarget; 2017 Oct; 8(50):87980-87996. PubMed ID: 29152135
[TBL] [Abstract][Full Text] [Related]
17. Impact of ramucirumab plus erlotinib on circulating cell-free DNA from patients with untreated metastatic non-small cell lung cancer with
Nishio K; Sakai K; Nishio M; Seto T; Visseren-Grul C; Carlsen M; Matsui T; Enatsu S; Nakagawa K
Transl Lung Cancer Res; 2023 Aug; 12(8):1702-1716. PubMed ID: 37691865
[TBL] [Abstract][Full Text] [Related]
18.
Lettig L; Sahnane N; Pepe F; Cerutti R; Albeni C; Franzi F; Veronesi G; Ogliari F; Pastore A; Tuzi A; Pinotti G; Bovio A; Verusio C; Giordano M; Troncone G; Sessa F; Malapelle U; Furlan D
Transl Lung Cancer Res; 2019 Oct; 8(5):584-592. PubMed ID: 31737495
[TBL] [Abstract][Full Text] [Related]
19. Exosome-based detection of EGFR T790M in plasma and pleural fluid of prospectively enrolled non-small cell lung cancer patients after first-line tyrosine kinase inhibitor therapy.
Kim Y; Shin S; Lee KA
Cancer Cell Int; 2021 Jan; 21(1):50. PubMed ID: 33435996
[TBL] [Abstract][Full Text] [Related]
20. Assessment of EGFR mutation status using cell-free DNA from bronchoalveolar lavage fluid.
Park S; Hur JY; Lee KY; Lee JC; Rho JK; Shin SH; Choi CM
Clin Chem Lab Med; 2017 Aug; 55(10):1489-1495. PubMed ID: 28195541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
